<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="82260">
  <stage>Registered</stage>
  <submitdate>4/09/2007</submitdate>
  <approvaldate>24/09/2007</approvaldate>
  <actrnumber>ACTRN12607000491460</actrnumber>
  <trial_identification>
    <studytitle>Research study into the effect of vibration platform training on bone health in postmenopausal women</studytitle>
    <scientifictitle>Research study into the efficacy of a new device for musculoskeletal health in osteopenic and osteoporotic populations at risk of fracture: a sequence of pilot projects leading to a major intervention</scientifictitle>
    <utrn />
    <trialacronym />
  </trial_identification>
  <conditions>
    <healthcondition>Osteoporotic Fracture</healthcondition>
    <conditioncode>
      <conditioncode1>Musculoskeletal</conditioncode1>
      <conditioncode2>Osteoporosis</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Vibration platform (12Hz, 0.3G, 20 minutes intermittent vibration [1 minute on, 30 seconds off], 8 weeks, 1-3 times per week)</interventions>
    <comparator>Placebo group (Placebo vibration platform, 20 minutes continuous, 1 times per week, 8 weeks)</comparator>
    <control>Placebo</control>
    <interventioncode>Treatment: Devices</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Blood Borne markers of Bone formation- OSTASE (bone specific alkaline phosphatase).</outcome>
      <timepoint>Baseline, 8 weeks</timepoint>
    </primaryOutcome>
    <primaryOutcome>
      <outcome>Blood Borne markers of Bone resorption- NTx (N-telopeptide X)</outcome>
      <timepoint>Baseline, 8 weeks</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Muscle strength- Bilateral Leg press 1 Repetition Maximum (1RM)/ Bilateral Chest Press 1RM</outcome>
      <timepoint>Baseline, 8 weeks</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Performance Based Testing (Stair Climb, Balance, Chair Stand, Habitual Gait Velocity and Maximum Gait Velocity)</outcome>
      <timepoint>Baseline, 8 weeks</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Peripheral quantitative computed tomography (pQCT)</outcome>
      <timepoint>Baseline</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>Currently postmenopausal for at least 1yr;
Free from diseases related to bone metabolism other that osteoporosis (e.g. hyperthyroidism); Willing to continue taking any supplements and/or bone altering medications currently being taken ; able to stand unassisted on the platform for a sustained period (e.g. up to 20 minutes); free from cognitive impairment; without terminal disease</inclusivecriteria>
    <inclusiveminage>0</inclusiveminage>
    <inclusiveminagetype>Not stated</inclusiveminagetype>
    <inclusivemaxage>0</inclusivemaxage>
    <inclusivemaxagetype>Not stated</inclusivemaxagetype>
    <inclusivegender>Females</inclusivegender>
    <healthyvolunteer>Yes</healthyvolunteer>
    <exclusivecriteria>Thyroid disease, Paget's disease, Chronic kidney disease, rheumatoid arthritis, multiple myeloma, vitamin D deficiency, hyperparathyroidism, inability to stand unassisted for sustained periods of time</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Prevention</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment>Both tested and subject were blinded to allocation. Allocation concealed by sealed opaque envelopes.</concealment>
    <sequence>Stratified allocation (years since menopause, medications, exerciser status) using a randomization table created by a computer software</sequence>
    <masking>Blinded (masking used)</masking>
    <assignment>Parallel</assignment>
    <designfeatures />
    <endpoint>Efficacy</endpoint>
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Not Applicable</phase>
    <anticipatedstartdate>18/05/2007</anticipatedstartdate>
    <actualstartdate />
    <anticipatedenddate />
    <actualenddate />
    <samplesize>60</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Recruiting</recruitmentstatus>
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate />
    <postcode>2096</postcode>
    <postcode>2092</postcode>
    <postcode>2100</postcode>
    <postcode>2099</postcode>
    <postcode>2095</postcode>
    <postcode>2093</postcode>
    <postcode>2099</postcode>
  </recruitment>
  <sponsorship>
    <primarysponsortype>University</primarysponsortype>
    <primarysponsorname>University of Sydney</primarysponsorname>
    <primarysponsoraddress>University of Sydney
Cumberland Campus
Faculty of Health Sciences
75 East St
Lidcombe
NSW</primarysponsoraddress>
    <primarysponsorcountry>Australia</primarysponsorcountry>
    <fundingsource>
      <fundingtype>University</fundingtype>
      <fundingname>University of Sydney</fundingname>
      <fundingaddress>University of Sydney
Cumberland Campus
Faculty of Health Sciences
75 East St
Lidcombe
NSW</fundingaddress>
      <fundingcountry>Australia</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>Other</sponsortype>
      <sponsorname>Dr Geraldine Naughton</sponsorname>
      <sponsoraddress>Australian Catholic University</sponsoraddress>
      <sponsorcountry>Australia</sponsorcountry>
    </secondarysponsor>
    <othercollaborator>
      <othercollaboratortype>University</othercollaboratortype>
      <othercollaboratorname>Australia Catholic University</othercollaboratorname>
      <othercollaboratoraddress>Strathfield
NSW</othercollaboratoraddress>
      <othercollaboratorcountry>Australia</othercollaboratorcountry>
    </othercollaborator>
  </sponsorship>
  <ethicsAndSummary>
    <summary>The primary purpose of the study is to investigate the effects of vibration platform training on bone health in postmenopausal women. The primary hypothesis is that vibration training will be associated with an increase in blood borne markers of bone metabolism after 8 weeks.</summary>
    <trialwebsite />
    <publication />
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>Human Research Ethics Committee (University of Sydney)</ethicname>
      <ethicaddress>University of Sydney
Camperdown Campus
Room L4.14, Main Quadrangle A14</ethicaddress>
      <ethicapprovaldate />
      <hrec>02-2004/7132</hrec>
      <ethicsubmitdate />
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
    <ethicscommitee>
      <ethicname>Human Research Ethics Committee (HREC)</ethicname>
      <ethicaddress>Universit of Sydney
Camperdown Campus
Sydney</ethicaddress>
      <ethicapprovaldate />
      <hrec />
      <ethicsubmitdate />
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>Prof. Maria Fiatarone Singh</name>
      <address>University of Sydney
CUmberland Campus
Faculty of Health Sciences
PO BOX 170
Lidcombe</address>
      <phone>0293519755</phone>
      <fax>0293519204</fax>
      <email>m.singh@usyd.edu.au</email>
      <country>Australia</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title />
      <name>Sarah Walker</name>
      <address>University of Sydney
CUmberland Campus
Faculty of Health Sciences
PO BOX 170
Lidcombe</address>
      <phone>0424600307</phone>
      <fax />
      <email>swal9910@mail.usyd.edu.au</email>
      <country>Australia</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title />
      <name>Sarah Walker</name>
      <address>University of Sydney
CUmberland Campus
Faculty of Health Sciences
PO BOX 170
Lidcombe</address>
      <phone>0424600307</phone>
      <fax />
      <email>swal9910@mail.usyd.edu.au</email>
      <country>Australia</country>
      <type>Updating Information</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>